These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37542285)

  • 1. Anti-glioma effect of ginseng-derived exosomes-like nanoparticles by active blood-brain-barrier penetration and tumor microenvironment modulation.
    Kim J; Zhu Y; Chen S; Wang D; Zhang S; Xia J; Li S; Qiu Q; Lee H; Wang J
    J Nanobiotechnology; 2023 Aug; 21(1):253. PubMed ID: 37542285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amelioration of colitis progression by ginseng-derived exosome-like nanoparticles through suppression of inflammatory cytokines.
    Kim J; Zhang S; Zhu Y; Wang R; Wang J
    J Ginseng Res; 2023 Sep; 47(5):627-637. PubMed ID: 37720571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ginseng-derived nanoparticles potentiate immune checkpoint antibody efficacy by reprogramming the cold tumor microenvironment.
    Han X; Wei Q; Lv Y; Weng L; Huang H; Wei Q; Li M; Mao Y; Hua D; Cai X; Cao M; Cao P
    Mol Ther; 2022 Jan; 30(1):327-340. PubMed ID: 34450250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-derived exosomes deliver the tumor suppressor miR-3591-3p to induce M2 macrophage polarization and promote glioma progression.
    Li M; Xu H; Qi Y; Pan Z; Li B; Gao Z; Zhao R; Xue H; Li G
    Oncogene; 2022 Oct; 41(41):4618-4632. PubMed ID: 36085418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosome-based nanoimmunotherapy targeting TAMs, a promising strategy for glioma.
    Luo H; Zhang H; Mao J; Cao H; Tao Y; Zhao G; Zhang Z; Zhang N; Liu Z; Zhang J; Luo P; Xia Y; Cheng Y; Xie Z; Cheng Q; Liu G
    Cell Death Dis; 2023 Apr; 14(4):235. PubMed ID: 37012233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginseng-derived nanoparticles reprogram macrophages to regulate arginase-1 release for ameliorating T cell exhaustion in tumor microenvironment.
    Lv Y; Li M; Weng L; Huang H; Mao Y; Yang DA; Wei Q; Zhao M; Wei Q; Rui K; Han X; Fan W; Cai X; Cao P; Cao M
    J Exp Clin Cancer Res; 2023 Nov; 42(1):322. PubMed ID: 38012650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth.
    Cao M; Yan H; Han X; Weng L; Wei Q; Sun X; Lu W; Wei Q; Ye J; Cai X; Hu C; Yin X; Cao P
    J Immunother Cancer; 2019 Nov; 7(1):326. PubMed ID: 31775862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo.
    Jia G; Han Y; An Y; Ding Y; He C; Wang X; Tang Q
    Biomaterials; 2018 Sep; 178():302-316. PubMed ID: 29982104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3.
    Pan Z; Zhao R; Li B; Qi Y; Qiu W; Guo Q; Zhang S; Zhao S; Xu H; Li M; Gao Z; Fan Y; Xu J; Wang H; Wang S; Qiu J; Wang Q; Guo X; Deng L; Zhang P; Xue H; Li G
    Mol Cancer; 2022 Jan; 21(1):16. PubMed ID: 35031058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M1 macrophage-derived exosomes containing miR-150 inhibit glioma progression by targeting MMP16.
    Yan P; Wang J; Liu H; Liu X; Fu R; Feng J
    Cell Signal; 2023 Aug; 108():110731. PubMed ID: 37244635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory tumor microenvironment responsive neutrophil exosomes-based drug delivery system for targeted glioma therapy.
    Wang J; Tang W; Yang M; Yin Y; Li H; Hu F; Tang L; Ma X; Zhang Y; Wang Y
    Biomaterials; 2021 Jun; 273():120784. PubMed ID: 33848731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
    Hu S; Ma J; Su C; Chen Y; Shu Y; Qi Z; Zhang B; Shi G; Zhang Y; Zhang Y; Huang A; Kuang Y; Cheng P
    Acta Biomater; 2021 Nov; 135():567-581. PubMed ID: 34506976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound Facilitates Naturally Equipped Exosomes Derived from Macrophages and Blood Serum for Orthotopic Glioma Treatment.
    Bai L; Liu Y; Guo K; Zhang K; Liu Q; Wang P; Wang X
    ACS Appl Mater Interfaces; 2019 Apr; 11(16):14576-14587. PubMed ID: 30900870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain-Cortex Microglia-Derived Exosomes: Nanoparticles for Glioma Therapy.
    Murgoci AN; Cizkova D; Majerova P; Petrovova E; Medvecky L; Fournier I; Salzet M
    Chemphyschem; 2018 May; 19(10):1205-1214. PubMed ID: 29327816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary M1 macrophages as multifunctional carrier combined with PLGA nanoparticle delivering anticancer drug for efficient glioma therapy.
    Pang L; Zhu Y; Qin J; Zhao W; Wang J
    Drug Deliv; 2018 Nov; 25(1):1922-1931. PubMed ID: 30465444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring innate immune cell dynamics in the glioma microenvironment by magnetic resonance imaging and multiphoton microscopy (MR-MPM).
    Karimian-Jazi K; Münch P; Alexander A; Fischer M; Pfleiderer K; Piechutta M; Karreman MA; Solecki GM; Berghoff AS; Friedrich M; Deumelandt K; Kurz FT; Wick W; Heiland S; Bendszus M; Winkler F; Platten M; Breckwoldt MO
    Theranostics; 2020; 10(4):1873-1883. PubMed ID: 32042342
    [No Abstract]   [Full Text] [Related]  

  • 17. Smart Nanomedicine to Enable Crossing Blood-Brain Barrier Delivery of Checkpoint Blockade Antibody for Immunotherapy of Glioma.
    Wang H; Chao Y; Zhao H; Zhou X; Zhang F; Zhang Z; Li Z; Pan J; Wang J; Chen Q; Liu Z
    ACS Nano; 2022 Jan; 16(1):664-674. PubMed ID: 34978418
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Gao H; Chu C; Cheng Y; Zhang Y; Pang X; Li D; Wang X; Ren E; Xie F; Bai Y; Chen L; Liu G; Wang M
    ACS Appl Mater Interfaces; 2020 Jun; 12(24):26880-26892. PubMed ID: 32441504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-Modified Novel Biomimetic Nanocarriers Improve Targeting and Therapeutic Efficacy in Glioma.
    Fu S; Liang M; Wang Y; Cui L; Gao C; Chu X; Liu Q; Feng Y; Gong W; Yang M; Li Z; Yang C; Xie X; Yang Y; Gao C
    ACS Appl Mater Interfaces; 2019 Jan; 11(2):1841-1854. PubMed ID: 30582685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxic glioma-derived exosomes deliver microRNA-1246 to induce M2 macrophage polarization by targeting TERF2IP via the STAT3 and NF-κB pathways.
    Qian M; Wang S; Guo X; Wang J; Zhang Z; Qiu W; Gao X; Chen Z; Xu J; Zhao R; Xue H; Li G
    Oncogene; 2020 Jan; 39(2):428-442. PubMed ID: 31485019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.